Cautionary statement regarding forward-looking statements | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ...

Definitive Healthcare Corp. (NASDAQ:DH) Q4 2023 Earnings Conference Call February 28, 2024 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Jason Krantz - Founder and Executive Chairman and Interim CEO Richard Booth - CFO Conference Call Participants Stephanie Davis - Barclays Craig Hettenbach - Morgan Stanley Craig Jones - Stifel Matthew Shea - Needham & Company Allen Lutz - Bank of America Jared Haase - William Blair Johnathan McCary - Raymond James George Hill - Deutsche Bank Operator ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of Registrant as specified in its Charter) Delaware 86-3988281 (State or other jurisdic ...

FRAMINGHAM, Mass., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare Corp. (“Definitive Healthcare”) (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that it will report financial results for its fourth quarter and full year ended December 31, 2023, on Wednesday, February 28, 2024 after market close. The company will host a conference call and webcast at 5:00 PM (ET) / 2:00 PM (PT) to discuss the company’s financial results. A live audio webcast of the event will ...

A downtrend has been apparent in Definitive Healthcare Corp. (DH) lately. While the stock has lost 5.8% over the past four weeks, it could witness a trend reversal as a hammer chart pattern was formed in its last trading session. This could mean that the bulls have been able to counteract the bears to help the stock find support.While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about ...

| --- | --- | --- | --- | --- | |-------|------------------|---------------|-------|-------| | | | | | | | | | | | | | | | | | | | | Third quarter | 2023 earnings | | | | | presentation | | | | | | November 2, 2023 | | | | Cautionary statement regarding forward-looking statements 2 Forward-looking statements in this press release are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, by t ...

Definitive Healthcare Corp. (NASDAQ:DH) Q3 2023 Earnings Conference Call November 2, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Robert Musslewhite - CEO Jason Krantz - Founder and Executive Chairman Rick Booth - CFO Conference Call Participants Craig Hettenbach - Morgan Stanley David Grossman - Stifel Glen Santangelo - Jefferies Matt Shea - Needham & Company Joe Vruwink - Baird Allen Lutz - Bank of America Johnathan McCary - Raymond James Jared Haase - William Blair George Hill ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 For the transition period from to or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) | Delaware | | 86-3988281 | | --- | ...

Definitive Healthcare Corp. (NASDAQ:DH) Q2 2023 Results Conference Call August 14, 2023 5:00 PM ET Company Participants Matt Ruderman - Chief Legal Officer Robert Musslewhite - Chief Executive Officer Jason Krantz - Founder and Executive Chairman Rick Booth - Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Matt Shea - Needham & Company Brian Peterson - Raymond James Allen Lutz - Bank of America David Grossman - Stifel Jonathan Yong - Credit Suisse George Hill - Deutsch ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-40815 Definitive Healthcare Corp. (Exact name of registrant as specified in its charter) | Delaware | | 86-3988281 | | --- | --- ...